Edarbyclor® for Hypertension: Uses, Dosage, Side Effects, and Costs

What Edarbyclor® Is and How It Works

Edarbyclor is a prescription blood pressure medication that combines azilsartan medoxomil (an angiotensin II receptor blocker, ARB) with chlorthalidone (a thiazide-like diuretic). It is taken by mouth once daily to lower elevated blood pressure in adults. Many people compare the cost of Edarbyclor without insurance when exploring treatment options. Typical strengths are 40/12.5 mg and 40/25 mg.

Azilsartan medoxomil blocks angiotensin II type 1 receptors. This relaxes blood vessels and reduces aldosterone-mediated sodium retention. Chlorthalidone increases sodium and water excretion in the kidneys, which lowers plasma volume and blood pressure. The combination provides additive blood pressure control and may help patients who are not adequately controlled on a single agent.

Youdrugstore is a licensed Canadian pharmacy headquartered in Manitoba; pharmacists review prescriptions before dispensing, and we offer brand and generic medicines at Canadian prices with online ordering and customer-service chat during posted hours.

Edarbyclor is indicated for the treatment of hypertension, as monotherapy or in combination with other antihypertensives. It can be used as initial therapy in patients likely to need multiple agents, or to replace separate components. It is not approved for pediatric use. Tablets can be taken with or without food.

Edarbyclor’s drug class is ARB plus thiazide-like diuretic. By addressing both vascular tone and volume, it can deliver meaningful reductions in systolic and diastolic pressure. Lifestyle measures and home blood pressure tracking often support treatment plans; learn more in our Hypertension condition page.

Dosage and Usage

• Starting dose: 40/12.5 mg once daily.
• May increase after 2 to 4 weeks based on response to 40/25 mg once daily (maximum).
• Replacement therapy: patients receiving azilsartan, chlorthalidone, or both may switch to the nearest equivalent strength.
• Take at the same time each day, with or without food. Swallow tablets whole with water.
• Missed dose: take when remembered unless it is near the next dose. Do not take two doses at once.
• Volume- or salt-depleted patients may be at risk of hypotension; consider correcting depletion before initiation.
• Use is not recommended in severe renal impairment or anuria. Monitor renal function and electrolytes, especially potassium, sodium, and magnesium.
• Avoid concomitant aliskiren in patients with diabetes; not recommended with aliskiren in renal impairment.

• Storage: store at 20–25 °C (68–77 °F); excursions 15–30 °C (59–86 °F). Keep tablets dry and in the original container with the lid tightly closed.
• Protect from moisture and excess heat. Do not store in a bathroom.
• Travel: keep in a carry-on bag, in original labeled packaging. Bring enough tablets for your trip plus extra.
• Do not use past the expiration date. Keep out of reach of children and pets.

Benefits and Savings

Edarbyclor offers once-daily dosing with two proven mechanisms. Many patients achieve greater reductions versus either azilsartan or chlorthalidone alone. The 40/12.5 mg and 40/25 mg strengths provide practical titration. Real-world use shows consistent blood pressure lowering when taken as directed.

Ordering Edarbyclor online from Youdrugstore can lower costs compared with typical US retail prices. Savings of 60–80% are common, including for those comparing the cost of Edarbyclor without insurance. Multi-month supplies may reduce the per-month price, and reorder reminders help you stay on schedule.

We also work with licensed, vetted international partner pharmacies to source authentic brand medicines, expanding choice while keeping pricing affordable.

For available offers, visit our edarbyclor coupon page.

Side Effects and Safety

• Common: dizziness, lightheadedness, increased urination, fatigue, nausea, diarrhea, muscle cramps, headache.
• Lab changes: low potassium or sodium, increased uric acid, slight increases in creatinine, changes in glucose or lipids.
• Less common: photosensitivity, gout flare, dry mouth, constipation, back pain.

Serious but rare risks include severe hypotension, acute kidney injury, significant electrolyte imbalances, syncope, or hypersensitivity reactions. ARBs carry a boxed warning for fetal toxicity; discontinue if pregnancy occurs. Do not use in anuric patients. Use caution with sulfonamide allergy due to the chlorthalidone component. Hypoglycemia can occur when combined with insulin or sulfonylureas; dose adjustments may be needed.

Onset Time

Initial blood pressure reductions often appear within the first week. The full effect usually develops over 2 to 4 weeks as steady-state levels and diuretic response stabilize. Lab monitoring of electrolytes and renal function is commonly done within the first few weeks after dose changes. Weight is not a target for this medication, but fluid loss may occur early.

Compare With Alternatives

Many patients respond well to an ARB plus diuretic. A widely used alternative is valsartan combined with hydrochlorothiazide. The chlorthalidone component in Edarbyclor has a longer half-life than hydrochlorothiazide, which some clinicians prefer for sustained 24-hour control. Consider Valsartan Hct if a valsartan-based combination is being evaluated.

Another approach is to pair an ARB with a calcium channel blocker instead of a diuretic. Separate components offer flexibility but add pill burden. For select patients, a beta blocker such as Bystolic® may be used for compelling indications like rate control or coronary disease, though beta blockers are not first-line for uncomplicated hypertension.

If Edarbyclor is not suitable, prescribers may consider monotherapy with an ARB like valsartan or other classes such as ACE inhibitors, dihydropyridine calcium channel blockers, or thiazide-type diuretics. These choices depend on comorbidities, tolerability, and target blood pressure goals.

Combination Therapy

• Edarbyclor plus calcium channel blocker (e.g., amlodipine) for further blood pressure reduction.
• Edarbyclor plus beta blocker when a beta blocker indication exists.
• Avoid dual renin-angiotensin system blockade (e.g., ARB plus ACE inhibitor or aliskiren) due to higher risk of renal issues and hyperkalemia.
• When used with insulin or sulfonylureas, consider reducing the insulin or sulfonylurea dose to lower hypoglycemia risk.

Patient Suitability and Cost-Saving Tips

Good candidates include adults with primary hypertension who need two agents or who failed to reach goals on a single drug. It may be helpful when 24-hour coverage is needed. It is not for children. Use caution in the elderly, those with kidney disease, or patients with a history of gout or electrolyte disturbances.

Do not use during pregnancy or in anuric patients. Avoid combining with aliskiren in diabetes, and avoid in severe renal impairment. Monitor potassium and sodium, especially in those on other diuretics, lithium, NSAIDs, or potassium supplements. Limit alcohol intake to reduce dizziness. Photosensitivity can occur; consider sun protection.

To lower the Edarbyclor price, consider larger fills when appropriate. Bulk promotions can reduce the monthly Edarbyclor cost. Set up reorder reminders so you do not run out. Patients often compare the cost of Edarbyclor without insurance across pharmacies; Canadian pricing from Youdrugstore can help stabilize out-of-pocket expenses.

For broader guidance on lifestyle measures that support medication, see our article How To Treat Hypertension Effective Methods And Tips.

Authoritative Sources

Edarbyclor official patient site

FDA Prescribing Information for azilsartan medoxomil/chlorthalidone

DailyMed drug labeling database

Order Edarbyclor® from Youdrugstore: add to cart, upload your prescription, and we ship with prompt, express shipping.

This page is for education only and does not replace advice from your healthcare professional. Always follow your prescriber’s directions and the medication guide that comes with your prescription.